Meet the Author Eleanor Malone Editor in Chief, Commercial Insights Eleanor directs editorial content produced by the Commercial Pharma Insights team (Scrip, Generics Bulletin and In Vivo) in the US and Europe, liaising closely with counterparts in policy and regulatory coverage and in Asia
While many research groups and corporate powerhouses Apple and Google to name two work furiously on non-invasive methods, for the foreseeable future diabetics remain stuck in a world where pins and needles are a necessary evil
10.1007/s40675-017-0071-6 72 JiangB.ShenR
Long-Term Use of Semaglutide: Safety, Stability and Follow-Up As people get close to their target weight or reach a steady range, it is normal to wonder what long-term treatment should look like
Pre-filled pens like Ozempic and Mounjaro typically use 31 or 32-gauge needles
Oral liposomal iron versus injectable iron sucrose for anemia treatment in non-dialysis chronic kidney disease patients: a non-inferiority study